stocks logo

ESTA

Establishment Labs Holdings Inc
$
30.350
+0.090(+0.300%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
30.815
Open
29.610
VWAP
30.33
Vol
214.51K
Mkt Cap
877.37M
Low
29.365
Amount
6.51M
EV/EBITDA(TTM)
--
Total Shares
27.51M
EV
1.00B
EV/OCF(TTM)
--
P/S(TTM)
5.15
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
41.11M
+10.61%
-0.828
+42.69%
51.85M
+17.52%
-0.541
-12.72%
51.74M
+28.62%
-0.500
-15.25%
Estimates Revision
The market is revising Upward the revenue expectations for Establishment Labs Holdings Inc. (ESTA) for FY2025, with the revenue forecasts being adjusted by 0.19% over the past three months. During the same period, the stock price has changed by 1.37%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.19%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+10.78%
In Past 3 Month
Stock Price
Go Up
up Image
+1.37%
In Past 3 Month
7 Analyst Rating
up Image
94.96% Upside
Wall Street analysts forecast ESTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ESTA is 59.17 USD with a low forecast of 54.00 USD and a high forecast of 62.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
1 Hold
0 Sell
Strong Buy
up Image
94.96% Upside
Current: 30.350
sliders
Low
54.00
Averages
59.17
High
62.00
Needham
Mike Matson
Hold
Initiates
n/a
2025-04-14
Reason
Needham initiated coverage of Establishment Labs with a Hold rating and no price target. The company's U.S. Motiva launch should serve as a "major growth driver" and a potential source of upside while its minimally invasive procedures may expand the breast implant market, the analyst tells investors in a research note. However, the firm says Establishment's international business has been weak, and that it worries the trade war could weigh on its international growth.
Stephens & Co.
Mason Carrico
Buy
Reiterates
$52
2025-03-06
Reason
Stephens & Co.
Mason Carrico
Buy
Reiterates
$52
2025-02-27
Reason
BTIG
Marie Thibault
Strong Buy
Maintains
$62 → $65
2024-10-14
Reason
BTIG raised the firm's price target on Establishment Labs to $65 from $62 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in MedTech. The sector had "solid returns" as Providers outperformed among healthcare sub-sectors at 10.5% for iShares U.S. Healthcare Providers ETF (IHF), and these results track largely in line with fundamental feedback during Q3 as procedure volumes have been healthy and demand is strong, the analyst tells investors in a research note. Channel checks in many sub-sectors also point to sustained procedure demand continuing into 2025 as demographics and low unemployment provide support, the firm added.
Citigroup
Joanne Wuensch
Hold
Maintains
$45 → $50
2024-10-01
Reason
Citigroup
Joanne Wuensch
Hold
Maintains
$41 → $45
2024-08-22
Reason

Valuation Metrics

The current forward P/E ratio for Establishment Labs Holdings Inc (ESTA.O) is -14.30, compared to its 5-year average forward P/E of -31.30. For a more detailed relative valuation and DCF analysis to assess Establishment Labs Holdings Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-31.30
Current PE
-14.30
Overvalued PE
-12.63
Undervalued PE
-49.98

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-83.36
Current EV/EBITDA
-60.66
Overvalued EV/EBITDA
1.81
Undervalued EV/EBITDA
-168.54

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
7.88
Current PS
4.13
Overvalued PS
10.59
Undervalued PS
5.17

Financials

Annual
Quarterly
FY2024Q4
YoY :
+41.05%
44.51M
Total Revenue
FY2024Q4
YoY :
-15.58%
-18.67M
Operating Profit
FY2024Q4
YoY :
+68.10%
-34.53M
Net Income after Tax
FY2024Q4
YoY :
+50.63%
-1.19
EPS - Diluted
FY2024Q4
YoY :
+76.36%
-22.52M
Free Cash Flow
FY2024Q4
YoY :
+5.03%
68.50
Gross Profit Margin - %
FY2024Q4
YoY :
-34.82%
-44.62
FCF Margin - %
FY2024Q4
YoY :
+19.17%
-77.57
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
677.2K
USD
4
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
162.2K
Volume
2
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
4
2.6M
Volume
Months
6-9
0
0.0
Volume
Months
0-12
10
1.5M
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

ESTA News & Events

Events Timeline

2025-02-26 (ET)
2025-02-26
16:01:26
Establishment Labs reports Q4 EPS ($1.19), consensus (66c)
select
2025-01-13 (ET)
2025-01-13
07:20:48
Establishment Labs sees FY24 revenue $166M-$166.5M, consensus $166.21M
select
2025-01-13
07:18:01
Establishment Labs CEO Juan Jose Chacon-Quiros to retire
select
Sign Up For More Events

News

4.0
04-14Benzinga
Correction: Needham Initiates Coverage On Establishment Labs Hldgs to Hold (Rating Change From Reiterate to Initiates)
3.0
04-10Newsfilter
Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12
4.0
04-03Business Insider
TD Cowen Keeps Their Buy Rating on Establishment Labs Holdings (ESTA)
Sign Up For More News

FAQ

arrow icon

What is Establishment Labs Holdings Inc (ESTA) stock price today?

The current price of ESTA is 30.35 USD — it has increased 0.3 % in the last trading day.

arrow icon

What is Establishment Labs Holdings Inc (ESTA)'s business?

arrow icon

What is the price predicton of ESTA Stock?

arrow icon

What is Establishment Labs Holdings Inc (ESTA)'s revenue for the last quarter?

arrow icon

What is Establishment Labs Holdings Inc (ESTA)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Establishment Labs Holdings Inc (ESTA)'s fundamentals?

arrow icon

How many employees does Establishment Labs Holdings Inc (ESTA). have?

arrow icon

What is Establishment Labs Holdings Inc (ESTA) market cap?